FIELD: biotechnologies.
SUBSTANCE: strain of human enterovirus A71 of subgenotype C4 is offered. The strain is deposited in the Collections of microorganisms of Federal State-Funded Science Institution State Scientific Centre of virology and bioengineering "Vector" of Rospotrebnadzor under the registration number V-670. The strain is intended for diagnostics, study of efficiency and creation of medical and preventive and vaccinal preparations. The strain is characterized by high reproductive activity, it is effectively replicated in the cell culture 293 A with development of obvious cytopathic effect in nutrient medium F12/DMEM with adding of foetal serum and gentamycin within 1-2 days of cultivation at 37°C.
EFFECT: invention allows to define effectively infectious activity of virus preparations, to cultivate virus biomass for preparation of diagnostic and vaccinal preparations.
2 dwg, 4 tbl, 3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| STRAIN OF ENTEROVIRUS COXSACKIE B6 SELECTIVELY INFECTING AND LYSING TUMOROUS HUMAN CELLS in vitro | 2012 |
|
RU2496873C1 |
| NON-PATHOGENIC STRAIN LEV82 OF HUMAN ENTEROVIRUS A, COXSACKIE SEROTYPE A7, FOR NON-SPECIFIC PREVENTION OF VIRAL INFECTIONS AND TREATMENT OF ONCOLOGICAL DISEASES | 2024 |
|
RU2824819C1 |
| METHOD FOR OBTAINING VIRUS-LIKE PARTICLES OF NOROVIRUS CONTAINING THE PROTEIN VP1 OF ENTEROVIRUS ECHOVIRUS 30, IN VITRO | 2022 |
|
RU2789354C1 |
| METHOD FOR AMPLIFYING THE VP1 REGION OF THE GENOME OF ENTEROVIRUS SPECIES ENTEROVIRUS B | 2021 |
|
RU2774424C1 |
| Virus hepatitis A hominis STRAIN FOR PRODUCING OF VACCINE AND DIAGNOSTIC PREPARATIONS | 2005 |
|
RU2306336C2 |
| METHOD FOR DIFFERENTIAL AMPLIFICATION OF VP1 REGION FRAGMENT OF ENTEROVIRUS GENOME ENTEROVIRUS A AND ENTEROVIRUS B | 2020 |
|
RU2743352C1 |
| STRAIN A1 RU 09RU2240 OF HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 SUBTYPE A USED FOR DIAGNOSING AND STUDYING EFFICACY OF THERAPEUTIC AND VACCINE PREPARATIONS | 2010 |
|
RU2420575C1 |
| STRAIN 02-AG RU 09RU3124 OF HUMAN IMMUNODEFICIENCY VIRUS TYPE 1, RECOMBINANT SUBTYPE 02-AG USED FOR DIAGNOSING AND STUDYING EFFICACY OF THERAPEUTIC AND VACCINE PREPARATIONS | 2010 |
|
RU2420574C1 |
| STRAIN 02-AGRU09RU2410 OF HUMAN IMMUNODEFICIENCY VIRUS TYPE 1, RECOMBINANT SUBTYPE 02-AG USED FOR DIAGNOSING AND STUDYING EFFICACY OF THERAPEUTIC AND VACCINE PREPARATIONS | 2010 |
|
RU2421518C1 |
| STRAIN A1RU09RU2255 OF HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 SUBTYPE A USED FOR DIAGNOSING AND STUDYING EFFICACY OF THERAPEUTIC AND VACCINE PREPARATIONS | 2010 |
|
RU2421516C1 |
